Pediatrix Medical Group, Inc.
MD
$14.93
$0.050.34%
NYSE
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Net Income | -16.70% | -64.00% | -371.37% | -344.85% | -169.38% |
Total Depreciation and Amortization | -27.38% | -10.91% | -5.05% | 3.84% | 4.76% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | 13.48% | 6.92% | 11,794.38% | 2,086.11% | 1,005.15% |
Change in Net Operating Assets | 448.17% | 858.85% | -31.46% | -66.39% | -150.39% |
Cash from Operations | 89.65% | 50.43% | -14.36% | -23.06% | -30.88% |
Capital Expenditure | 36.80% | 33.92% | 17.14% | 2.07% | -7.09% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | 100.00% | -22.50% | -689.86% | -689.86% | -215.98% |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | 19.62% | 36.23% | 57.45% | -89.66% | 0.77% |
Cash from Investing | 49.81% | 26.51% | 2.34% | -42.18% | -26.25% |
Total Debt Issued | -84.69% | -49.89% | -62.35% | -63.34% | -46.77% |
Total Debt Repaid | 65.88% | 48.71% | 65.95% | 62.32% | 44.14% |
Issuance of Common Stock | -26.45% | -25.94% | -21.97% | -19.34% | -12.04% |
Repurchase of Common Stock | -131.33% | -85.31% | 55.63% | 95.66% | 98.83% |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 90.66% | 90.25% | -592.47% | -223.09% | -218.54% |
Cash from Financing | -66.54% | 43.67% | 86.70% | 55.64% | 52.60% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | 4,754.86% | 147.00% | 560.63% | 264.50% | 277.63% |